LIME Study (LFB IVIg MMN Efficacy Study)

NCT01951924 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Motor Neuron Disease

Interventions

DRUG: Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL)
DRUG: Biological: Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL)

Sponsor

Laboratoire français de Fractionnement et de Biotechnologies

Collaborators

[object Object]